Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Feb 1;112(2):216-217.
doi: 10.1093/jnci/djz120.

Response to Habel and Buist

Marc D Ryser  1   2 , E Shelley Hwang  3
Affiliations
Comment

Response to Habel and Buist

Marc D Ryser et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Net risk of ipsilateral invasive breast cancer (iIBC) in patients without locoregional treatment, based on US National Cancer Institute’s Surveillance, Epidemiology, and End Results program (1992–2014). The cumulative net risk of iIBC is shown for patients diagnosed between 1992 and 1999, 2000 and, and 2008 and 2014, respectively. The number of patients at risk is shown beneath the figure. Dx = date of diagnosis.
See this image and copyright information in PMC

Comment on

References

    1. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478–488. - PMC - PubMed
    1. Subhedar P, Olcese C, Patil S, Morrow M, Van Zee KJ.. Decreasing recurrence rates for ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery over 30 years. Ann Surg Oncol. 2015;22(10):3273–3281. - PMC - PubMed
    1. Cronin PA, Olcese C, Patil S, Morrow M, Van Zee KJ.. Impact of age on risk of recurrence of ductal carcinoma in situ: outcomes of 2996 women treated with breast-conserving surgery over 30 years. Ann Surg Oncol. 2016;23(9):2816–2824. - PMC - PubMed
    1. Johnson C, Peace S, Adamo P, Fritz A, Percy-Laurry A, Edwards B.. The 2007 multiple primary and histology coding rules. National Cancer Institute, Surveillance, Epidemiology and End Results Program. Bethesda, MD: National Cancer Institute; 2007.
    1. Hwang ES, Hyslop T, Lynch T, et al. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open. 2019;9(3):e026797. - PMC - PubMed

MeSH terms